Business
Personalis, Inc. to Present New Data at the Society for Immunotherapy of Cancer (SITC) 35th Annual Meeting
MENLO PARK, Calif.--(BUSINESS WIRE)-- Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for population sequencing and cancer, today announced
About this update from Personalis, Inc.
[{"type":"text","content":" MENLO PARK, Calif.--(BUSINESS WIRE)--\nPersonalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for population sequencing and cancer, today announced that the company will participate in the Society for Immunotherapy of Cancer (SITC) Annual Meeting online, November 11-14, including poster presentations on November 11th – 13th.\n\nThe company will showcase ImmunoID NeXT™, the first platform to enable comprehensive analysis of both a tumor and its immune microenvironment from a single sample. ImmunoID NeXT™ can be used to investigate the key tumor and immune-related areas of cancer biology, consolidating multiple oncology biomarker assays into one and maximizing the biological information that can be generated from a precious tumor specimen.\n\nFollowing is a list of abstracts that will be presented at the meeting.\n\nScientific Poster Presentations\n\n\n\nPoster Number & Category\n\n\n\n\nTitle & Presenter\n\n\n\n\nDay & Time\n\n\n\n\n\n29\n\n\nBiomarkers, Immune Monitoring, and Novel Technologies\n\n\n\n\nProfiling Tumor Circulating Cell-Free DNA with an Enhanced Whole-Exome to Enable Sensitive Assessment of Somatic Mutations\n\n\n\nPresenter: Simo V. Zhang, PhD\n\n\n\n\nNOV 11 | 5:15 – 5:45 PM EST\nand\n\n\nNOV 13 | 4:40 – 5:10 PM EST\n\n\n\n\n\n57\n\n\nBiomarkers, Immune Monitoring, and Novel Technologies\n\n\n\n\nPrecision neoantigen discovery using novel algorithms and expanded HLA-ligandome datasets\n\n\n\nPresenter: Dattatreya Mellacheruvu, PhD\n\n\n\n\nNOV 11 | 5:15 – 5:45 PM EST\nand\n\n\nNOV 13 | 4:40 – 5:10 PM EST\n\n\n\n\n\n67\n\n\nBiomarkers, Immune Monitoring, and Novel Technologies\n\n\n\n\nB-cell receptor heavy chain repertoire profiling using an augmented transcriptome\n\n\n\nPresenter: Eric Levy, Ph.D.\n\n\n\n\nNOV 11 | 5:15 – 5:45 PM EST\nand\n\n\nNOV 13 | 4:40 – 5:10 PM EST\n\n\n\n\n\n73\n\n\nBiomarkers, Immune Monitoring, and Novel Technologies\n\n\n\n\nOrthogonally and functionally validated algorithm for detecting HLA loss of heterozygosity\n\n\n\nPresenter: Rachel M. Pyke, PhD\n\n\n\n\nNOV 11 | 5:15 – 5:45 PM EST\nand\n\n\nNOV 13 | 4:40 – 5:10 PM EST\n\n\n\n\nFollowing are details of an industry-sponsored symposium which will be presented at the meeting.\n\nIndustry Sponsor Symposium\n\n\n\nPresentation Category\n\n\n\n\nTitle & Presenter\n\n\n\n\nDay & Time\n\n\n\n\n\nSponsored Symposia\n\n\n\n\nMa...